A chromosomal translocation involving breakpoints at 11q13.1 leads to the fusion of MALAT1 with different genes or noncoding regions, such as Alpha‐TFEB, and activation of MALAT1 in renal cell cancer.112. Here, MALAT1 is linked to renal cell adenocarcinoma.